Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NICE approves glargine

Richard Holt

    Diabetes, Obesity & Metabolism
    |March 27, 2003
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Harmful anachronism: World Athletics reinstates gene testing to participate in women's competitions.

    British journal of sports medicine·2026
    Same author

    Obesity and Schizophrenia: Results of a Feasibility Study with Semaglutide to Assist Weight Loss.

    Advances in therapy·2025
    Same author

    GJA8-associated developmental eye disorders: a new multicentre study highlights mutational hotspots and genotype-phenotype correlations.

    European journal of human genetics : EJHG·2025
    Same author

    Deletion upstream of MAB21L2 highlights the importance of evolutionarily conserved non-coding sequences for eye development.

    Nature communications·2024
    Same author

    Clinical and functional heterogeneity associated with the disruption of retinoic acid receptor beta.

    Genetics in medicine : official journal of the American College of Medical Genetics·2023
    Same author

    Individuals with heterozygous variants in the Wnt-signalling pathway gene <i>FZD5</i> delineate a phenotype characterized by isolated coloboma and variable expressivity.

    Ophthalmic genetics·2023
    Same journal

    Relationship Between hsCRP, Glycaemic Control and Response to Sotagliflozin in Type 1 Diabetes: A Post Hoc Analysis of the inTandem3 Trial.

    Diabetes, obesity & metabolism·2026
    Same journal

    Early Weight Regain After GLP-1 Receptor Agonist Discontinuation: Mechanisms and Implications for Treatment De-Escalation Strategies.

    Diabetes, obesity & metabolism·2026
    Same journal

    First-Line Dapagliflozin, Metformin, or Combination Therapy in Type 2 Diabetes: Vascular and Molecular Outcomes of a Randomised Controlled Trial.

    Diabetes, obesity & metabolism·2026
    Same journal

    Trends in Prevalence of Diabetes, Pre-Diabetes, and Cardiometabolic Risk Factor Control Among U.S. Adults, 2013-2023.

    Diabetes, obesity & metabolism·2026
    Same journal

    Metabolic Risk-Attributable Dementia Burden: A Life-Course and Cautious Attribution Perspective.

    Diabetes, obesity & metabolism·2026
    Same journal

    A Highly Powered Large Outcomes Randomised Controlled Trial Will Usually, but Not Always, Have Balanced Groups at Baseline.

    Diabetes, obesity & metabolism·2026
    See all related articles